Niederman, Michael S.

Publications

Sort by

Co-Author Network

selected publications

What every intensivist should know about..Patient safety huddles in the ICU. Journal of critical care. 2024 Academic Article GET IT
Community-acquired pneumonia: the best candidates for clarithromycin - Authors' reply. The Lancet. Respiratory medicine. 2024 Letter GET IT
Aspiration Pneumonia. Seminars in respiratory and critical care medicine. 2024 Academic Article GET IT
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. The Lancet. Respiratory medicine. 2024 Academic Article GET IT
Letter from the United States: An update on the New York experience with COVID-19. Respirology (Carlton, Vic.). 2023 Letter GET IT
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive care medicine. 2023 Academic Article GET IT
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. The European respiratory journal. 2023 Academic Article GET IT
Management of pneumonia in the critically ill. Minerva medica. 2023 Academic Article GET IT
Severe community-acquired pneumonia. European respiratory review : an official journal of the European Respiratory Society. 2022 Review GET IT
What COVID-19 Has Taught Us: Ventilator-associated Pneumonia Is Back!. American journal of respiratory and critical care medicine. 2022 Editorial Article GET IT
Risk Factors and Algorithms for the Empirical Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. Seminars in respiratory and critical care medicine. 2022 Academic Article GET IT
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies. The journal of allergy and clinical immunology. In practice. 2021 Academic Article GET IT
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study. Critical care (London, England). 2021 Academic Article GET IT
Management of pneumonia in critically ill patients. BMJ (Clinical research ed.). 2021 Review GET IT
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method. The Lancet. Infectious diseases. 2021 Review GET IT
Initial antimicrobial management of sepsis. Critical care (London, England). 2021 Information Resource GET IT
Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 2021 Academic Article GET IT
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges. Current opinion in pulmonary medicine. 2021 Academic Article GET IT
Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial Pneumonia. Annals of the American Thoracic Society. 2021 Academic Article GET IT
Pneumonia. Nature reviews. Disease primers. 2021 Information Resource GET IT
Times cited: 4
How low can we go in community-acquired pneumonia therapy?. Lancet (London, England). 2021 Article GET IT
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature. Expert review of vaccines. 2021 Information Resource GET IT
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence. Expert review of vaccines. 2021 Information Resource GET IT
Times cited: 2
Antibiotic Use in Sepsis: How and Why Less Can Really Mean More (Survival). American journal of respiratory and critical care medicine. 2021 Editorial Article GET IT
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). European respiratory review : an official journal of the European Respiratory Society. 2020 Information Resource GET IT
Times cited: 81
Updates on community acquired pneumonia management in the ICU. Pharmacology & therapeutics. 2020 Information Resource GET IT
Times cited: 60
Letter from the United States: A New York experience with COVID-19. Respirology (Carlton, Vic.). 2020 Letter GET IT
Times cited: 1
The INHALE trial: multiple reasons for a negative result - Authors' reply. The Lancet. Infectious diseases. 2020 Article GET IT
Times cited: 1
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Chest. 2020 Information Resource GET IT
Times cited: 107
Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM. Annals of the American Thoracic Society. 2020 Academic Article GET IT
Times cited: 59
The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States. Chest. 2020 Academic Article GET IT
Times cited: 2
Natural enemy or friend? Pneumonia in the very elderly critically ill patient. European respiratory review : an official journal of the European Respiratory Society. 2020 Editorial Article GET IT
25th International Symposium on Infections in the Critically Ill Patient. Medical sciences (Basel, Switzerland). 2020 Conference Paper GET IT
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial. The Lancet. Infectious diseases. 2019 Academic Article GET IT
Times cited: 19
Survival benefit associated with clarithromycin in severe community-acquired pneumonia: A matched comparator study. International journal of antimicrobial agents. 2019 Academic Article GET IT
Times cited: 4
Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia. Journal of clinical medicine. 2019 Academic Article GET IT
Update in Lung Infections and Tuberculosis 2018. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials. Infectious diseases and therapy. 2019 Academic Article GET IT
Times cited: 3
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2019 Academic Article GET IT
Times cited: 7
Clinical Impact of Antimicrobial Resistance: Using New Tools to Answer Old Questions. Chest. 2019 Editorial Article GET IT
Times cited: 1
Aspiration Pneumonia. Reply. The New England journal of medicine. 2019 Article GET IT
Adjunctive Nebulized Antibiotics: What Is Their Place in ICU Infections?. Frontiers in medicine. 2019 Information Resource GET IT
Times cited: 16
Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections. Current opinion in pulmonary medicine. 2019 Editorial Article GET IT
Times cited: 1
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Academic Article GET IT
Times cited: 12
Aspiration Pneumonia. The New England journal of medicine. 2019 Information Resource GET IT
Times cited: 106
24th International Symposium on Infections in the Critically Ill Patient. Medical sciences (Basel, Switzerland). 2019 Academic Article GET IT
Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive care medicine. 2019 Information Resource GET IT
Times cited: 96
Respiratory Infections: An Ongoing Challenge with a Promising Future. Clinics in chest medicine. 2018 Editorial Article GET IT
Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia. Chest. 2018 Academic Article GET IT
Times cited: 10
Beat around the bush for VA-LRTI. Intensive care medicine. 2018 Editorial Article GET IT
Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?. Current opinion in critical care. 2018 Information Resource GET IT
Times cited: 8
Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study. Pneumonia (Nathan Qld.). 2018 Academic Article GET IT
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia. ERJ open research. 2018 Academic Article GET IT
Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU. American journal of respiratory and critical care medicine. 2018 Article GET IT
Times cited: 22
Imaging for the Management of Community-Acquired Pneumonia: What to Do if the Chest Radiograph Is Clear. Chest. 2018 Editorial Article GET IT
Times cited: 5
23rd International Symposium on Infections in the Critically Ill Patient. Medical sciences (Basel, Switzerland). 2018 Conference Paper GET IT
Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome. Medicina intensiva. 2017 Academic Article GET IT
Times cited: 13
Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia. Intensive care medicine. 2017 Academic Article GET IT
Times cited: 15
Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial. PloS one. 2017 Academic Article GET IT
Times cited: 21
The research agenda in VAP/HAP: next steps. Intensive care medicine. 2017 Academic Article GET IT
Times cited: 6
Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia. The Journal of infection. 2017 Academic Article GET IT
Times cited: 7
Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia. Chest. 2017 Academic Article GET IT
Times cited: 11
Serum procalcitonin and the admission decision in CAP. The Lancet. Respiratory medicine. 2016 Article GET IT
Times cited: 2
The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia. Annals of the American Thoracic Society. 2016 Academic Article GET IT
Times cited: 38
Community-acquired pneumonia related to intracellular pathogens. Intensive care medicine. 2016 Information Resource GET IT
Times cited: 39
Lessons learned from 2 decades of CAP therapy data: ways to improve patient management. Journal of thoracic disease. 2016 Article GET IT
Times cited: 2
Improving outcomes in community-acquired pneumonia. Current opinion in pulmonary medicine. 2016 Information Resource GET IT
Times cited: 8
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia. The European respiratory journal. 2016 Article GET IT
Times cited: 10
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa. Chest. 2016 Academic Article GET IT
Times cited: 52
Outcomes and Prognostic Features of Patients With Influenza Requiring Hospitalization and Receiving Early Antiviral Therapy: A Prospective Multicenter Cohort Study. Chest. 2016 Academic Article GET IT
Times cited: 23
The road forward in the management of Acinetobacter infections in the ICU. Intensive care medicine. 2015 Editorial Article GET IT
Times cited: 1
Why is Acinetobacter baumannii a problem for critically ill patients?. Intensive care medicine. 2015 Academic Article GET IT
Times cited: 4
Bacteraemia in outpatients with community-acquired pneumonia. The European respiratory journal. 2015 Article GET IT
Times cited: 6
Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study. BMC pulmonary medicine. 2015 Academic Article GET IT
Times cited: 7
Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP). PloS one. 2015 Academic Article GET IT
Times cited: 8
Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?. American journal of respiratory and critical care medicine. 2015 Editorial Article GET IT
Times cited: 13
Respiratory tract infections in community and healthcare settings: epidemiological, diagnostic and management challenges. Current opinion in pulmonary medicine. 2015 Editorial Article GET IT
Ventilator-associated pneumonia prevention: response to Silvestri et al. Intensive care medicine. 2015 Article GET IT
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015 Academic Article GET IT
Times cited: 311
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis. The European respiratory journal. 2015 Academic Article GET IT
Times cited: 35
Managing ventilator complications in a "VACuum" of data. Chest. 2015 Editorial Article GET IT
Times cited: 4
World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance. Medicina intensiva. 2014 Academic Article GET IT
Times cited: 7
Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive care medicine. 2014 Information Resource GET IT
Times cited: 125
Year in review 2013: Critical Care--respiratory infections. Critical care (London, England). 2014 Information Resource GET IT
Times cited: 9
An Economic Model to Compare the Different Empiric and First/Second Line Treatment Regimens for Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014 Academic Article GET IT
Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Critical care medicine. 2014 Academic Article GET IT
Times cited: 108
Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid. Clinical therapeutics. 2014 Academic Article GET IT
Times cited: 19
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Critical care (London, England). 2014 Academic Article GET IT
Times cited: 18
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study. Respirology (Carlton, Vic.). 2014 Academic Article GET IT
Times cited: 16
Response. Chest. 2014 Article GET IT
Assessment of severity of ICU-acquired pneumonia and association with etiology. Critical care medicine. 2014 Academic Article GET IT
Times cited: 29
Reply to Yamamoto et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014 Article GET IT
Year in review 2012: Critical Care--respiratory infections. Critical care (London, England). 2013 Information Resource GET IT
Times cited: 1
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Academic Article GET IT
Times cited: 91
Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Critical care medicine. 2013 Academic Article GET IT
Times cited: 39
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. International journal of antimicrobial agents. 2013 Article GET IT
Times cited: 17
Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia?. Chest. 2013 Academic Article GET IT
Times cited: 35
Nosocomial pneumonia: lessons learned. Critical care clinics. 2013 Information Resource GET IT
Times cited: 30
Preparing for the unexpected: lessons learned about respiratory infection from the Japanese tsunami of 2011. Chest. 2013 Editorial Article GET IT
Times cited: 1
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Respirology (Carlton, Vic.). 2013 Academic Article GET IT
Times cited: 24
Acute lower respiratory infections in developing countries. Lancet (London, England). 2013 Article GET IT
Times cited: 16
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive care medicine. 2013 Academic Article GET IT
Times cited: 92
Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia?. Infectious disease clinics of North America. 2012 Information Resource GET IT
Times cited: 20
Pulmonary infections and resistance to antibiotics: recent information. Expert review of anti-infective therapy. 2012 Conference Paper GET IT
Times cited: 1
The Barcelona Declaration from the World Alliance against Antibiotic Resistance: engagement of intensivists. Critical care (London, England). 2012 Editorial Article GET IT
Times cited: 5
Update in respiratory infections 2011. American journal of respiratory and critical care medicine. 2012 Information Resource GET IT
Times cited: 2
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Academic Article GET IT
Times cited: 396
BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. Intensive care medicine. 2011 Academic Article GET IT
Times cited: 118
Community-acquired pneumonia: an unfinished battle. The Medical clinics of North America. 2011 Information Resource GET IT
Times cited: 54
Treatment of hospital-acquired pneumonia. The Lancet. Infectious diseases. 2011 Article GET IT
De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?. Clinics in chest medicine. 2011 Information Resource GET IT
Times cited: 35
Respiratory tract infections: advances in diagnosis, management and prevention. Clinics in chest medicine. 2011 Editorial Article GET IT
Distinguishing chemical pneumonitis from bacterial aspiration: still a clinical determination. Critical care medicine. 2011 Editorial Article GET IT
Times cited: 2
Year in review 2010: tuberculosis, pleural diseases, respiratory infections. Respirology (Carlton, Vic.). 2011 Information Resource GET IT
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Academic Article GET IT
Times cited: 227
Pneumonia complicating pregnancy. Clinics in chest medicine. 2010 Information Resource GET IT
Times cited: 40
Management of pneumonia in the nursing home. Chest. 2010 Information Resource GET IT
Times cited: 21
Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new 'speed limit'?. Thorax. 2010 Editorial Article GET IT
Times cited: 11
Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches. Current medical research and opinion. 2010 Information Resource GET IT
Times cited: 28
Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma. Journal of the American Medical Directors Association. 2010 Editorial Article GET IT
Times cited: 17
Management of community-acquired pneumonia: a review and update. Therapeutic advances in respiratory disease. 2010 Information Resource GET IT
Times cited: 37
Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us?. Chest. 2010 Editorial Article GET IT
Times cited: 10
Can one plus one ever equal three in the antibiotic therapy of sepsis?. Critical care medicine. 2010 Editorial Article GET IT
Times cited: 3
Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010 Conference Paper GET IT
Times cited: 9
Fighting vampires and ventilator-associated pneumonia: is silver the magic bullet?. Chest. 2010 Editorial Article GET IT
Times cited: 3
Year in review 2009: Respiratory infections, tuberculosis, pleural diseases and lung cancer. Respirology (Carlton, Vic.). 2010 Information Resource GET IT
Times cited: 1
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ (Clinical research ed.). 2010 Academic Article GET IT
Times cited: 229
Fluoroquinolones in the management of community-acquired pneumonia. International journal of clinical practice. 2010 Information Resource GET IT
Times cited: 25
Is lifelong anticoagulation worth the risk in patients with unprovoked DVT?. Annals of internal medicine. 2009 Article GET IT
Pneumonia severity index Class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. 2007. Chest. 2009 Article
Cardiovascular biomarkers in the ICU. Current opinion in critical care. 2009 Information Resource GET IT
Times cited: 12
Community-acquired pneumonia: the U.S. perspective. Seminars in respiratory and critical care medicine. 2009 Information Resource GET IT
Times cited: 42
Road ahead to respiratory health: experts chart future research directions. Respirology (Carlton, Vic.). 2009 Information Resource GET IT
Times cited: 9
Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009 Academic Article GET IT
Times cited: 117
Standardized care for nosocomial pneumonia is a valuable tool to improve patient outcomes: how do we get intensivists to listen?. Critical care medicine. 2009 Editorial Article GET IT
Times cited: 3
Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Information Resource GET IT
Times cited: 50
Guideline tyranny: a response to the article by Baum and Kaltsas. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Article GET IT
Times cited: 2
A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respiratory medicine. 2008 Academic Article GET IT
Times cited: 63
How can we improve the management and outcome of pneumonia in the elderly?. The European respiratory journal. 2008 Editorial Article GET IT
Times cited: 9
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. The European respiratory journal. 2008 Academic Article GET IT
Times cited: 70
Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2008 Academic Article GET IT
Times cited: 97
Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury. Chest. 2008 Academic Article GET IT
Times cited: 44
Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008 Academic Article GET IT
Times cited: 149
Pneumonia in the older patient. Clinics in chest medicine. 2007 Information Resource GET IT
Times cited: 29
Clinical presentation and diagnostic workup for community-acquired pneumonia: the Gulf Corporation Council CAP Working Group consensus statement. Journal of chemotherapy (Florence, Italy). 2007 Academic Article GET IT
Times cited: 2
Management and prevention strategies for community-acquired pneumonia in the Gulf Corporation Council. Journal of chemotherapy (Florence, Italy). 2007 Academic Article GET IT
Times cited: 13
Microbiology of community-acquired pneumonia in the Gulf Corporation Council states. Journal of chemotherapy (Florence, Italy). 2007 Academic Article GET IT
Times cited: 20
Rationale for producing evidence-based guidelines for community-acquired pneumonia in the Gulf Corporation Council. Journal of chemotherapy (Florence, Italy). 2007 Academic Article GET IT
Times cited: 4
The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Archives of internal medicine. 2007 Academic Article GET IT
Times cited: 40
A prediction model for bacterial etiology in acute exacerbations of COPD. Infection. 2007 Academic Article GET IT
Times cited: 55
Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infection control and hospital epidemiology. 2007 Academic Article GET IT
Times cited: 118
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest. 2007 Academic Article GET IT
Times cited: 91
Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest. 2007 Academic Article GET IT
Times cited: 92
De-escalation therapy in ventilator-associated pneumonia. Current opinion in critical care. 2006 Information Resource GET IT
Times cited: 56
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006 Academic Article GET IT
Times cited: 236
The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia. Seminars in respiratory and critical care medicine. 2006 Information Resource GET IT
Times cited: 30
Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Information Resource GET IT
Times cited: 65
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. The European respiratory journal. 2006 Academic Article GET IT
Times cited: 187
Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds. The European respiratory journal. 2006 Editorial Article GET IT
Times cited: 53
Health-care-associated pneumonia: a new therapeutic paradigm. Chest. 2005 Editorial Article GET IT
Times cited: 26
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Academic Article GET IT
Times cited: 78
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest. 2005 Academic Article GET IT
Times cited: 75
Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005 Information Resource GET IT
Times cited: 16
Reexamining quinolone use in the intensive care unit: use them right or lose the fight against resistant bacteria. Critical care medicine. 2005 Editorial Article GET IT
Times cited: 18
Antimicrobial therapy of community-acquired pneumonia. Infectious disease clinics of North America. 2004 Information Resource GET IT
Times cited: 37
Therapy of ventilator-associated pneumonia: what more can we do to use less antibiotics?. Critical care medicine. 2004 Editorial Article GET IT
Times cited: 10
Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004 Editorial Article GET IT
Times cited: 6
Review of treatment guidelines for community-acquired pneumonia. The American journal of medicine. 2004 Information Resource GET IT
Times cited: 30
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. The Journal of antimicrobial chemotherapy. 2004 Academic Article GET IT
Times cited: 94
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials. Current medical research and opinion. 2004 Academic Article GET IT
Times cited: 16
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin. Current medical research and opinion. 2004 Academic Article GET IT
Times cited: 14
Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax. 2004 Academic Article GET IT
Times cited: 212
A Retrospective Evaluation of Fluoroquinolone Antibacterial Selection in a U.S. Community Hospital. Today's Therapeutic Trends. 2004 Article
Does the presence of antibodies justify the use of antibiotics in exacerbations of chronic bronchitis?. American journal of respiratory and critical care medicine. 2004 Editorial Article GET IT
Times cited: 1
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. Treatments in respiratory medicine. 2004 Academic Article GET IT
Times cited: 44
What is the prognosis for using the pneumonia severity index to make site-of-care decisions in community-acquired pneumonia?. Chest. 2003 Editorial Article GET IT
Times cited: 13
Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. Journal of intensive care medicine. 2003 Information Resource GET IT
Times cited: 42
Diagnosis and treatment of rhinovirus respiratory infections. Chest. 2003 Information Resource GET IT
Times cited: 38
Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Critical care medicine. 2003 Academic Article GET IT
Times cited: 24
Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Critical care medicine. 2003 Academic Article GET IT
Times cited: 383
Appropriate use of antimicrobial agents: challenges and strategies for improvement. Critical care medicine. 2003 Information Resource GET IT
Times cited: 91
Community-acquired pneumonia in elderly patients. Clinics in geriatric medicine. 2003 Information Resource GET IT
Times cited: 28
Community-acquired pneumonia. The Israel Medical Association journal : IMAJ. 2003 Information Resource GET IT
Granulocyte colony-stimulating factor for severe pneumonia: what do we do when the best laid plans for men (and mice and rats...) fail?. Critical care medicine. 2003 Editorial Article GET IT
Times cited: 2
How do we achieve adequate therapy for severe infection?. Critical care medicine. 2003 Editorial Article GET IT
Times cited: 8
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002 Information Resource GET IT
Times cited: 192
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. Chest. 2002 Academic Article GET IT
Times cited: 35
What is the natural history of resolution of nosocomial pneumonia?. Seminars in respiratory and critical care medicine. 2002 Academic Article GET IT
Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Archives of internal medicine. 2002 Academic Article GET IT
Times cited: 301
The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. Archives of internal medicine. 2002 Academic Article GET IT
Times cited: 73
Can optimal management prevent mortality in ventilator-associated pneumonia?. Critical care medicine. 2002 Editorial Article GET IT
How do we optimize outcomes for patients with severe community-acquired pneumonia?. Intensive care medicine. 2002 Editorial Article GET IT
Times cited: 10
Nosocomial pneumonia. Current opinion in infectious diseases. 2002 Information Resource GET IT
Times cited: 18
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?. The European respiratory journal. 2002 Information Resource GET IT
Times cited: 20
Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest. 2002 Academic Article GET IT
Times cited: 101
Pneumonia treatment process and quality. Archives of internal medicine. 2002 Article GET IT
Times cited: 12
Acute exacerbations of chronic obstructive pulmonary disease. Annals of internal medicine. 2002 Article GET IT
Times cited: 1
Community-acquired pneumonia: Management controversies, part 1. Journal of Respiratory Diseases. 2002 Article
Can guidelines for the treatment of respiratory infections lead to reduced rates of antibiotic resistance?. Seminars in respiratory infections. 2001 Information Resource GET IT
Times cited: 7
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia. Chest. 2001 Academic Article GET IT
Times cited: 69
Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states : 1993, 1995, and 1997. Chest. 2001 Academic Article GET IT
Times cited: 160
Impact of antibiotic resistance on clinical outcomes and the cost of care. Critical care medicine. 2001 Information Resource GET IT
Times cited: 147
Bacteria and COPD exacerbations redux. Chest. 2001 Article GET IT
Times cited: 7
Management of suspected ventilator-associated pneumonia. Annals of internal medicine. 2000 Article GET IT
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 2000 Academic Article GET IT
Adequate empirical therapy minimizes the impact of diagnostic methods in patients with ventilator-associated pneumonia. Critical care medicine. 2000 Editorial Article GET IT
Times cited: 14
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. Antimicrobial agents and chemotherapy. 2000 Academic Article GET IT
Times cited: 67
Differential patterns of apoptosis in resolving and nonresolving bacterial pneumonia. American journal of respiratory and critical care medicine. 2000 Academic Article GET IT
Times cited: 17
Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest. 2000 Academic Article GET IT
Times cited: 211
Antibiotic therapy of exacerbations of chronic bronchitis. Seminars in respiratory infections. 2000 Information Resource GET IT
Times cited: 43
Why can't I see clearly now? I have a meta-analysis!. Critical care medicine. 1999 Editorial Article GET IT
Times cited: 4
Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest. 1999 Academic Article GET IT
Times cited: 91
Inflammation in severe pneumonia: act locally, not globally. Critical care medicine. 1999 Editorial Article GET IT
Times cited: 7
HIV disease, persistent fever, nonresolving pneumonia, tuberculosis. Patient Care. 1999 Article
Treatment cost of acute exacerbations of chronic bronchitis. Clinical therapeutics. 1999 Academic Article GET IT
[Clinical contribution of the newer fluoroquinolones in acute bacterial exacerbation of chronic bronchitis]. Medicina. 1999 Academic Article GET IT
Times cited: 3
Community-Acquired Pneumonia: Defining the problem. Infections in Medicine. 1998 Article
Respiratory Infection in the Critically Ill: Mechanisms and the Role of Apoptosis in the Response to Infection. Sepsis. 1998 Article
Community-acquired pneumonia. Disease-a-month : DM. 1998 Information Resource GET IT
Times cited: 24
Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation. Chest. 1998 Academic Article GET IT
Times cited: 74
Severe community-acquired pneumonia. Assessment of severity criteria. American journal of respiratory and critical care medicine. 1998 Academic Article GET IT
Times cited: 293
Role of quinolones in treatment of pneumonia and acute exacerbations of chronic bronchitis. Infectious Diseases in Clinical Practice. 1998 Article
Empirical therapy for community-acquired pneumonia. Annals of internal medicine. 1998 Article GET IT
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. Clinical therapeutics. 1998 Academic Article GET IT
Times cited: 70
The cost of treating community-acquired pneumonia. Clinical therapeutics. 1998 Academic Article GET IT
Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest. 1998 Academic Article GET IT
Times cited: 362
A "closed" medical intensive care unit (MICU) improves resource utilization when compared with an "open" MICU. American journal of respiratory and critical care medicine. 1998 Academic Article GET IT
Times cited: 194
Introduction: mechanisms and management of COPD: we can do better--it's time for a re-evaluation. Chest. 1998 Academic Article GET IT
Strategies for prevention of community-acquired pneumonia. Seminars in respiratory infections. 1998 Information Resource GET IT
Times cited: 4
Bronchoscopy for ventilator-associated pneumonia: show me the money (outcome benefit)!. Critical care medicine. 1998 Editorial Article GET IT
Times cited: 16
Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. American journal of respiratory and critical care medicine. 1998 Academic Article GET IT
Times cited: 305
Update in pulmonary medicine. Annals of internal medicine. 1998 Information Resource GET IT
Times cited: 13
Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Critical care medicine. 1997 Academic Article GET IT
Times cited: 178
Is "crop rotation" of antibiotics the solution to a "resistant" problem in the ICU?. American journal of respiratory and critical care medicine. 1997 Editorial Article GET IT
Times cited: 80
Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group. Clinical therapeutics. 1997 Academic Article GET IT
Evidence based medicine in critical care: will it take us over the cutting edge?. Critical care medicine. 1997 Editorial Article GET IT
Times cited: 4
Devising strategies for preventing nosocomial pneumonia--should we ignore the stomach?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1997 Editorial Article GET IT
Times cited: 41
Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997 Academic Article GET IT
Times cited: 800
Treatment of hospital-acquired pneumonia. Seminars in Respiratory and Critical Care Medicine. 1997 Article
Clinical pathways in an acute care setting: Community-acquired pneumonia. Infectious Diseases in Clinical Practice. 1996 Article
Diagnosis and treatment of nosocomial pneumonia. Current Opinion in Critical Care. 1996 Article
Health outcomes in infectious diseases: A clinician's perspective of pneumonia management. Infections in Medicine. 1996 Article
Hospitalized patients with community-acquired pneumonia: Overview of ats guidelines and initial management. Infectious Diseases in Clinical Practice. 1996 Article
Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996 Academic Article GET IT
Times cited: 156
Apoptosis and the histologic stage of pneumonia: Does the severity of pneumonia correlate with the apoptosis index?. Chest. 1996 Article
Systemic inflammatory response syndrome in patients with and without cardiac disease. Chest. 1996 Article
Respiratory infections. An opportunity for integrated disease management. Chest. 1996 Editorial Article GET IT
Times cited: 2
Community-acquired pneumonia. The New England journal of medicine. 1996 Article GET IT
Times cited: 1
New etiopathogenic concepts of ventilator-associated pneumonia. Seminars in respiratory infections. 1996 Information Resource GET IT
Times cited: 10
Acute bronchitis in adults and children. Patient Care. 1996 Article
When chronic bronchitis turns acute. Patient Care. 1996 Article
Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster?. American journal of respiratory and critical care medicine. 1995 Academic Article GET IT
Times cited: 51
Cytokines affect pseudomonas binding to tracheal cells via a neutrophil-mediated process. American journal of respiratory and critical care medicine. 1995 Academic Article GET IT
Times cited: 7
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Critical care medicine. 1995 Academic Article GET IT
Times cited: 289
Respiratory infections in the 1990s. Current opinion in pulmonary medicine. 1995 Editorial Article GET IT
Times cited: 2
New approaches to prevention and treatment of nosocomial pneumonia. Seminars in thoracic and cardiovascular surgery. 1995 Information Resource GET IT
Times cited: 7
Questionable susceptibility reporting in a multicenter trial. Antimicrobial agents and chemotherapy. 1995 Article GET IT
An antimicrobial approach to nosocomial pneumonia. Contemporary internal medicine. 1995 Information Resource GET IT
Times cited: 2
Prevention of ventilator-associated pneumonia. An attainable goal?. Clinics in chest medicine. 1995 Information Resource GET IT
Times cited: 12
Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin. Drugs. 1995 Academic Article GET IT
Times cited: 5
The pathogenesis of airway colonization: lessons learned from the study of bacterial adherence. The European respiratory journal. 1994 Editorial Article GET IT
Times cited: 36
Empirical therapy of community-acquired pneumonia. Seminars in respiratory infections. 1994 Information Resource GET IT
Times cited: 21
New challenges in critical care medicine. Contemporary internal medicine. 1994 Editorial Article GET IT
Treatment of severe pneumonia with ciprofloxacin or imipenem. Antimicrobial agents and chemotherapy. 1994 Article GET IT
Times cited: 2
Predicting bacteremia in critically ill patients: a clinically relevant effort?. Intensive care medicine. 1994 Editorial Article GET IT
Times cited: 5
Response to "Treatment guidelines for nosocomial pneumonia: Agreeing to disagree". The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 1994 Academic Article GET IT
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrobial agents and chemotherapy. 1994 Academic Article GET IT
Times cited: 430
Benefits of a multidisciplinary pulmonary rehabilitation program. Chest. 1994 Article GET IT
Times cited: 2
Severe pneumonia in the elderly. Clinics in geriatric medicine. 1994 Information Resource GET IT
Times cited: 34
Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 1993 Academic Article GET IT
Nonresolving and slowly resolving pneumonia. Diagnosis and management in the elderly patient. Clinics in chest medicine. 1993 Information Resource GET IT
Times cited: 21
Nosocomial pneumonia in the elderly patient. Chronic care facility and hospital considerations. Clinics in chest medicine. 1993 Information Resource GET IT
Times cited: 30
Noninfectious respiratory disease in pregnancy. Cleveland Clinic journal of medicine. 1993 Information Resource GET IT
Times cited: 4
Antimicrobial treatment of community acquired pneumonia in adults: A conference report. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses. 1993 Academic Article GET IT
Pneumonia complicating pregnancy. Clinics in chest medicine. 1992 Information Resource GET IT
Times cited: 50
The application of decision analysis to critical care medicine. Intensive care world. 1992 Information Resource GET IT
Times cited: 3
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. The American journal of medicine. 1992 Academic Article GET IT
Times cited: 66
Characterization of Pseudomonas aeruginosa adherence to cultured hamster tracheal epithelial cells. American journal of respiratory cell and molecular biology. 1991 Academic Article GET IT
Times cited: 14
Diagnosing nosocomial pneumonia: to brush or not to brush. Journal of intensive care medicine. 1991 Editorial Article GET IT
Times cited: 3
Atypical manifestations of pneumonia in the elderly. Clinics in chest medicine. 1991 Information Resource GET IT
Times cited: 46
Neutrophil-endothelial cell interaction in critical illness. Chest. 1991 Academic Article GET IT
Times cited: 17
Benefits of a multidisciplinary pulmonary rehabilitation program. Improvements are independent of lung function. Chest. 1991 Academic Article GET IT
Times cited: 143
Impact of anaesthetic procedures on colonization defences of the tracheobronchial tree. Bailliere's Clinical Anaesthesiology. 1991 Article GET IT
Sepsis syndrome. Infectious Diseases Newsletter. 1991 Article GET IT
Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia. A common clinical sequence. Clinics in chest medicine. 1990 Information Resource GET IT
Times cited: 90
Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest. 1990 Academic Article GET IT
Times cited: 98
Respiratory infections and acute lung injury in systemic illness. Clinics in chest medicine. 1989 Information Resource GET IT
Times cited: 28
Patterns and routes of tracheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest. 1989 Academic Article GET IT
Times cited: 123
Pulmonary edema with low pulmonary capillary wedge pressure after acute myocardial infarction: Clinical features and prognostic implications. Journal of Critical Care. 1989 Article GET IT
"When the pneumonia doesn't get better". Clinics in chest medicine. 1987 Information Resource GET IT
Times cited: 28
Strategies for the prevention of pneumonia. Clinics in chest medicine. 1987 Information Resource GET IT
Times cited: 6
Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest. 1987 Academic Article GET IT
Cardiovascular function in secondary pulmonary hypertension. Heart & lung : the journal of critical care. 1986 Information Resource GET IT
Times cited: 16
Pathophysiology of the adult respiratory distress syndrome. What have we learned from human studies?. Critical care clinics. 1986 Information Resource GET IT
Times cited: 20
The interaction of infection and the adult respiratory distress syndrome. Critical care clinics. 1986 Information Resource GET IT
Times cited: 15
Bacterial adherence to respiratory tract cells. Relationships between in vivo and in vitro pH and bacterial attachment. The American review of respiratory disease. 1986 Academic Article GET IT
Times cited: 28
Pneumonia in the elderly. Clinics in geriatric medicine. 1986 Information Resource GET IT
Times cited: 62
Influence of sputum IgA and elastase on tracheal cell bacterial adherence. The American review of respiratory disease. 1986 Academic Article GET IT
Times cited: 57
Considerations in the management of patients with asthma and hypertension. Practical Cardiology. 1986 Article
AIDS in a bodybuilder using anabolic steroids. The New England journal of medicine. 1984 Article GET IT
Times cited: 56
Demonstration of a free elastolytic metalloenzyme in human lung lavage fluid and its relationship to alpha 1-antiprotease. The American review of respiratory disease. 1984 Academic Article GET IT
Times cited: 25
Nutritional status and bacterial binding in the lower respiratory tract in patients with chronic tracheostomy. Annals of internal medicine. 1984 Academic Article GET IT
Respiratory infection complicating long-term tracheostomy. The implication of persistent gram-negative tracheobronchial colonization. Chest. 1984 Academic Article GET IT
New techniques for the assessment of interstitial lung disease. Radiologic clinics of North America. 1983 Academic Article GET IT
Times cited: 7
Comparison of bacterial adherence to ciliated and squamous epithelial cells obtained from the human respiratory tract. The American review of respiratory disease. 1983 Academic Article GET IT
Nosocomial pulmonary infections in acute respiratory failure. Respiratory Care. 1983 Article
Serial thoracenteses in parapneumonic effusions. The New England journal of medicine. 1981 Article GET IT
Times cited: 3

more ...

less ...

Background

education and training

A.B., Boston University 1977
M.D., Boston University School of Medicine 1977

Contact

full name

Michael S. Niederman

primary email

msn9004@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Michael S. Niederman Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage